SUMMARY Splenic pathology was analysed in 73 patients with immune thrombocytopenic purpura who underwent splenectomy for bleeding that had been resistant to adrenocorticosteroids. The mean splenic weight was 100 g. The only notable macroscopic feature was the prominence of Malpighian corpuscles in 15 cases. Microscopic examination showed formation of germinal centres in the lymphoid tissue of the white pulp in 40 cases, prominence of the histiocytes in the red pulp in 18 cases, and infiltration with neutrophils in the same area in 49 cases. Myeloid metaplasia throughout the splenic tissue was minimal in 58 cases, moderate in 15, and extreme in two. No distinguishing features were found in the spleen from patients who had not received previous immunosuppressive treatment (n = 3), those treated with prednisone (1 mg/kg/day) for a median of 14 days (n = 62), or those who had received the same dose of prednisone and additional azathioprine or cyclophosphamide (2 mg/kg/day) for a median of four weeks (n = 8).
The typical histological features of spleens removed from patients with idiopathic immune thrombocytopenia are reported to be lymphoid hyperplasia with formation of germinal centres, infiltration of the splenic cords with granulocytes, and variable proliferation of histiocytes in the red pulp. '-4 In addition, splenic haematopoiesis of minimal degree has been described, although it is unusual for this to be a prominent feature; in rare cases it may reach a degree comparable with that seen in the myeloproliferative syndrome.5 This study re-examined splenic pathology in patients with immune thrombocytopenia, focusing on the range of myeloid metaplasia that may occur and seeking histological correlations with the previous administration of adrenocorticosteroids or other immunosuppressive drugs that are potential modifiers of splenic histology,6 the titre of antiplatelet antibody, the age of the patient, and the presence of underlying systemic disorders that may be associated with secondary immune thrombocytopenia.
Material and methods
The spleens from 73 patients diagnosed as having Accepted for publication 13 May 1985 immune thrombocytopenia were reviewed. All subjects fulfilled the criteria for this diagnosis7 and were managed according to a standard protocol whereby splenectomy was undertaken for symptomatic refractory thrombocytopenia after treatment with adrenocorticosteroids alone for a median of two weeks (group 1, n = 62); after treatment with adrenocorticosteroids combined with azathioprine for a median of four weeks (group 2, n = 8); or after all previous treatment had been refused (group 3, n = 3). Patients with associated lymphoproliferative disorders were excluded. Included were patients with systemic lupus erythematosus (n = 8), hyperthyroidism (n = 6), immune haemolytic anaemia (n = 3), and recent viral illnesses (n = 3). Table 1 shows the distribution of the patients by age and sex. The clinical details and response to treatment of the 148 patients from whom the subgroup undergoing splenectomy were drawn are available from PJ.8 All spleens were weighed and examined macroscopically immediately after surgery and samples selected for histological examination after fixation in buffered 10% formol saline. Sections were stained with haemotoxylin and eosin and, using a simple scoring system, were assessed for the degree of lymphoid hyperplasia, infiltration by granulocytes, histocytic proliferation, and splenic Hayes, Jacobs, Wood, Dent spleens, and common (17) to very common (one) in only 17 cases (Fig. 1 ). Histiocytes were normally distributed in 18 spleens. Thirty seven cases showed aggregates of foamy histiocytes, resembling lipogranulomas in or adjacent to the white pulp ( Fig. 2 ): these are a common incidental finding in normal spleens. A moderate (13) to high (5) diffuse proliferation of histiocytes in the red pulp was noted in 18 cases (Fig. 3) . Neutrophils infiltrated the red pulp variably. No increase in numbers was noted in 24 cases. In 30 cases granulocytes were seen to be concentrated in the red pulp immediately surrounding the lymphoid tissue. 19 cases exhibited a more diffuse infiltration throughout the cords of the red pulp. Haematopoiesis was either absent (19 cases) or limited to an occasional megakaryocyte or early myeloid cell in 39 cases. More extensive extramedullary haematopoiesis was present in 15 spleens (13 with moderate evidence, two high), and in two this reached the degree usually encountered in the myeloproliferative syndrome,'2 in which groups of erythroblasts, myeloid precursors, and megakaryocytes were present in the sinusoids (Fig. 4) . Occasional haematopoietic cells were also noted in the splenic cords.
CORRELATION WITH TREATMENT
In none of the three treatment groups were distinctive histological features present. Specifically, neither the two week course of adrenocorticosteroids that preceded splenectomy (n = 62) nor the four week course of adrenocorticosteroids combined with immunosuppressive agents (n = 8) produced Three points are germane to this discussion. Firstly, the classically described features of proliferation of lymphoid germinal centres and neutrophilic infiltration in the spleens of patients with immune thrombocytopenia'l4 could not be shown consistently in the present study. Secondly, although diffuse proliferation of foamy histiocytes has been reported to be a feature associated with a systemic response to treatment,'3 many of the spleens from patients in the present study failed to show this feature. The most likely explanation for this discordant observation is the short time during which our patients received medical management with adrenocorticosteroids before splenectomy.
Finally, although the presence of extramedullary haematopoiesis in the spleen has been previously reported'4 the present survey indicates that such myeloid metaplasia is usually limited to the presence of occasional megakaryocytes or metamyelocytes in the sinusoids. The prevalence of moderate to high amounts of haematopoietic tissue in the spleen was far lower than has been reported before.3s In addition, this tissue was situated mainly in the sinusoids, with only occasional cells visible in the splenic cords. Such a pattern could not be distinguished from that which occurs in the myeloproliferative syndrome. These findings confirm the presence of generally minimal extramedullary haematopoiesis in the spleen of patients with immune thrombocytopenia and emphasise the rarity with which this reaches a degree comparable with that found in the myeloproliferative syndrome. Furthermore, our observation that splenic histopathology in patients with immune thrombocytopenia, whether idiopathic or secondary, is not modified by previous adrenocorticosteroid or immunosuppressive treatment is at variance with earlier reports but may in part be explained by the short period of medical management that our patients received before undergoing splenectomy.
Finally, in patients with immune thrombocytopenia no distinguishing features were present on histopathological criteria that could be correlated with antiplatelet antibody titres or with systemic lupus erythematosus, hyperthyroidism, immune haemolysis, or viral disease. In particular, the perivascular onion skin fibrosis and degenerative changes in the capsular collagen described in systemic lupus erythematosus were not shown.'5
